Tag: SAVE trial
CIRSE 2026: Two-year trial results support sirolimus-eluting balloon for patients with...
Treatment with a sustained-release sirolimus-eluting balloon (SLR) for patients with failing arteriovenous fistulas (AVFs) was associated with higher target-lesion primary patency (TLPP) through to...
CIRSE 2025: SAVE trial reports higher efficacy for Selution SLR DEB...
A first report from the SAVE prospective, multicentre, single-blinded randomised controlled trial of the Selution Sustained Limus Release (SLR; Cordis) drug-eluting balloon (DEB) in...